These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Magnetic resonance imaging for noninvasive assessment of lung fibrosis onset and progression: cross-validation and comparison of different magnetic resonance imaging protocols with micro-computed tomography and histology in the bleomycin-induced mouse model. Vande Velde G; De Langhe E; Poelmans J; Dresselaers T; Lories RJ; Himmelreich U Invest Radiol; 2014 Nov; 49(11):691-8. PubMed ID: 24872004 [TBL] [Abstract][Full Text] [Related]
4. Administration of bleomycin via the oropharyngeal aspiration route leads to sustained lung fibrosis in mice and rats as quantified by UTE-MRI and histology. Egger C; Cannet C; Gérard C; Jarman E; Jarai G; Feige A; Suply T; Micard A; Dunbar A; Tigani B; Beckmann N PLoS One; 2013; 8(5):e63432. PubMed ID: 23667616 [TBL] [Abstract][Full Text] [Related]
5. Role of interleukin-6 in bleomycin-induced lung inflammatory changes in mice. Saito F; Tasaka S; Inoue K; Miyamoto K; Nakano Y; Ogawa Y; Yamada W; Shiraishi Y; Hasegawa N; Fujishima S; Takano H; Ishizaka A Am J Respir Cell Mol Biol; 2008 May; 38(5):566-71. PubMed ID: 18096870 [TBL] [Abstract][Full Text] [Related]
6. IL-10 inhibits inflammation but does not affect fibrosis in the pulmonary response to bleomycin. Kradin RL; Sakamoto H; Jain F; Zhao LH; Hymowitz G; Preffer F Exp Mol Pathol; 2004 Jun; 76(3):205-11. PubMed ID: 15126102 [TBL] [Abstract][Full Text] [Related]
7. Bleomycin sensitivity of mice expressing dominant-negative p53 in the lung epithelium. Ghosh S; Mendoza T; Ortiz LA; Hoyle GW; Fermin CD; Brody AR; Friedman M; Morris GF Am J Respir Crit Care Med; 2002 Sep; 166(6):890-7. PubMed ID: 12231503 [TBL] [Abstract][Full Text] [Related]
8. Upregulation of the p75 but not the p55 TNF-alpha receptor mRNA after silica and bleomycin exposure and protection from lung injury in double receptor knockout mice. Ortiz LA; Lasky J; Lungarella G; Cavarra E; Martorana P; Banks WA; Peschon JJ; Schmidts HL; Brody AR; Friedman M Am J Respir Cell Mol Biol; 1999 Apr; 20(4):825-33. PubMed ID: 10101016 [TBL] [Abstract][Full Text] [Related]
9. Bleomycin induces strain-dependent alterations in the pattern of epithelial cell-specific marker expression in mouse lung. Daly HE; Baecher-Allan CM; Barth RK; D'Angio CT; Finkelstein JN Toxicol Appl Pharmacol; 1997 Feb; 142(2):303-10. PubMed ID: 9070353 [TBL] [Abstract][Full Text] [Related]
10. Murine susceptibility to radiation-induced pulmonary fibrosis is influenced by a genetic factor implicated in susceptibility to bleomycin-induced pulmonary fibrosis. Haston CK; Travis EL Cancer Res; 1997 Dec; 57(23):5286-91. PubMed ID: 9393751 [TBL] [Abstract][Full Text] [Related]
11. VEGFR-2 antagonist SU5416 attenuates bleomycin-induced pulmonary fibrosis in mice. Ou XM; Li WC; Liu DS; Li YP; Wen FQ; Feng YL; Zhang SF; Huang XY; Wang T; Wang K; Wang X; Chen L Int Immunopharmacol; 2009 Jan; 9(1):70-9. PubMed ID: 18976720 [TBL] [Abstract][Full Text] [Related]
12. E- and P-selectins synergistically inhibit bleomycin-induced pulmonary fibrosis. Horikawa M; Fujimoto M; Hasegawa M; Matsushita T; Hamaguchi Y; Kawasuji A; Matsushita Y; Fujita T; Ogawa F; Takehara K; Steeber DA; Sato S Am J Pathol; 2006 Sep; 169(3):740-9. PubMed ID: 16936251 [TBL] [Abstract][Full Text] [Related]
14. Modulation of bleomycin-induced pulmonary toxicity in the hamster by the antioxidant amifostine. Nici L; Santos-Moore A; Kuhn C; Calabresi P Cancer; 1998 Nov; 83(9):2008-14. PubMed ID: 9806661 [TBL] [Abstract][Full Text] [Related]
15. Inhibitor of differentiation 1 promotes endothelial survival in a bleomycin model of lung injury in mice. Zhang H; Lawson WE; Polosukhin VV; Pozzi A; Blackwell TS; Litingtung Y; Chiang C Am J Pathol; 2007 Oct; 171(4):1113-26. PubMed ID: 17717145 [TBL] [Abstract][Full Text] [Related]
16. A TSP-1 synthetic peptide inhibits bleomycin-induced lung fibrosis in mice. Chen Y; Wang X; Weng D; Tian L; Lv L; Tao S; Chen J Exp Toxicol Pathol; 2009 Jan; 61(1):59-65. PubMed ID: 18579356 [TBL] [Abstract][Full Text] [Related]
17. Modulation of bleomycin-induced lung fibrosis by serotonin receptor antagonists in mice. Fabre A; Marchal-Sommé J; Marchand-Adam S; Quesnel C; Borie R; Dehoux M; Ruffié C; Callebert J; Launay JM; Hénin D; Soler P; Crestani B Eur Respir J; 2008 Aug; 32(2):426-36. PubMed ID: 18321937 [TBL] [Abstract][Full Text] [Related]
18. Fine mapping of the major bleomycin-induced pulmonary fibrosis susceptibility locus in mice. Bergeron ME; Stefanov A; Haston CK Mamm Genome; 2018 Oct; 29(9-10):670-679. PubMed ID: 30173367 [TBL] [Abstract][Full Text] [Related]
19. Animal models of pulmonary fibrosis. Gharaee-Kermani M; Ullenbruch M; Phan SH Methods Mol Med; 2005; 117():251-9. PubMed ID: 16118457 [TBL] [Abstract][Full Text] [Related]
20. Mobilization of bone marrow cells by CSF3 protects mice from bleomycin-induced lung injury. Zhang F; Zhang L; Jiang HS; Chen XY; Zhang Y; Li HP; Zhang RX; Zheng H; Chu JX; Chen XJ Respiration; 2011; 82(4):358-68. PubMed ID: 21778693 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]